×
App Icon
The Standard e-Paper
Home To Bold Columnists
★★★★ - on Play Store
Download App

Ozempic faces Sh258 billion lawsuit amid weight-loss craze

Ozempic faces Sh258 billion lawsuit amid weight-loss craze
Ozempic faces Sh258 billion lawsuit amid weight-loss craze (Photo: iStock)

Ozempic, once hailed as a groundbreaking treatment for type 2 diabetes, has now become the focus of global attention for an entirely different reason: its role in the weight-loss craze sweeping social media.

Celebrities and influencers have fuelled its popularity as the latest quick-fix for shedding pounds, sparking viral before-and-after transformations across platforms like Instagram and TikTok.

Premium Article

Get Full Access for Ksh299/Week.

Fact-first reporting that puts you at the heart of the newsroom. Subscribe for full access.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902
Support Independent Journalism

Stand With Bold Journalism.
Stand With The Standard.

Journalism can't be free because the truth demands investment. At The Standard, we invest time, courage and skills to bring you accurate, factual and impactful stories. Subscribe today and stand with us in the pursuit of credible journalism.

Pay via
M - PESA
VISA
Airtel Money
Secure Payment Kenya's most trusted newsroom since 1902